Healthequity Share Based Compensation Over Time

HQY
 Stock
  

USD 63.01  0.34  0.54%   

With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Please check Healthequity Performance and Healthequity Correlation.
  
Share Based Compensation is likely to rise to about 56.9 M in 2022.

Healthequity Quarterly Share Based Compensation

13.99 Million

Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
5.3 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Share Based Compensation Analysis

Compare Healthequity and related stocks such as Cisco Systems, Pfizer Inc, Home Depot, Exxon Mobil Corp, Chevron Corp, Dupont Denemours, JP Morgan Chase, McDonalds Corp, and Caterpillar Share Based Compensation Over Time
Select Fundamental

2010201120122013201420152016201720182019202020212022
CSCO1.3 B1.3 B1.3 B1.3 B1.3 B1.6 B1.6 B1.6 B1.6 B1.6 B1.8 BB1.9 B
PFE349 M419 M481 M523 M586 M669 M691 M840 M949 M718 M718 M825.7 M783.5 M
HD225 M225 M225 M225 M225 M251 M251 M251 M251 M251 M399 M399 M373.2 M
DD(23 M)(23 M)(76 M)(23 M)(42 M)(42 M)(42 M)(42 M)(42 M)(42 M)(42 M)(37.8 M)(40.8 M)
JPM2.7 B2.7 B2.5 B2.5 B2.5 B2.5 B2.5 B2.5 B2.5 B2.5 B2.5 B2.3 B2.3 B
MCD86.2 M86.2 M93.4 M89.1 M112.8 M110 M131.3 M117.5 M125.1 M109.6 M92.4 M139.2 M136.8 M

Healthequity and related stocks such as Cisco Systems, Pfizer Inc, Home Depot, Exxon Mobil Corp, Chevron Corp, Dupont Denemours, JP Morgan Chase, McDonalds Corp, and Caterpillar Share Based Compensation description

A component of Net Cash Flow from Operations representing the total amount of noncash; equity-based employee remuneration. This may include the value of stock or unit options; amortization of restricted stock or units; and adjustment for officers' compensation. As noncash; this element is an add back when calculating net cash generated by operating activities using the indirect method.

My Equities

My Current Equities and Potential Positions

AMN - USA Stock
Amn Healthcare Services
AMN
Amn Healthcare Fama & French Business Services
Business Services
Fama & French Classification
RegionNorth America
ExchangeNew York Stock Exchange
USD 112.11
Please check Healthequity Performance and Healthequity Correlation. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
5.3 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.